<DOC>
	<DOCNO>NCT01671787</DOCNO>
	<brief_summary>This open-label study evaluate multiple dos GS-7340 versus Tenofovir disoproxil fumarate ( TDF ) .</brief_summary>
	<brief_title>A Phase 1b Study Assessing GS-7340 Treatment-Naive Adults With Chronic Hepatitis B</brief_title>
	<detailed_description>This randomize , open-label , active-controlled study whose primary objective evaluate safety efficacy several dose GS-7340 . This study evaluate safety , viral kinetics , antiviral activity 4 different dos GS-7340 28 day therapy . In addition , study evaluate antiviral activity optimal dose GS-7340 versus 300mg Tenofovir disoproxil fumarate ( TDF ) 28 day therapy .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Hepatitis B , Chronic</mesh_term>
	<mesh_term>Tenofovir</mesh_term>
	<criteria>Must 18 65 year age Must Screening plasma HBV DNA ≥ 2x10^3 IU/mL Must chronic HBV infection least 6 month Must estimate creatinine clearance ( CLCr ) ≥ 70 mL/min Not pregnant nursing Women must nonchildbearing potential OR childbearing potential confirm negative pregnancy test Consistent correct use recommend method birth control men woman Pregnant lactate subject Receipt antiHBV nucleoside/nucleotide therapy . Subjects fail prior Interferon treatment , great 6 month prior screen , permit participate study screen Known coinfection HIV , hepatitis C virus ( HCV ) hepatitis D virus ( HDV ) Presence autoimmune disorder History liver disease Hepatitis B History Gilbert 's Disease Any sign decompensated liver disease Known suspect cirrhosis Evidence hepatocellular carcinoma Presence history cardiovascular disease , cardiomyopathy , and/or cardiac conduction abnormality Electrolyte abnormalities History treatment permanently alter gastric condition Alcohol substance abuse History bleed diathesis Significant bone disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2014</verification_date>
	<keyword>Hepatitis B</keyword>
	<keyword>HBV</keyword>
	<keyword>GS-7340</keyword>
	<keyword>TDF</keyword>
	<keyword>Tenofovir disoproxil fumarate</keyword>
	<keyword>Gilead</keyword>
	<keyword>Viread</keyword>
</DOC>